Evaluation of Lenalidomide, Doxorubicin and Dexamethasone (RAD) in Patients With Relapsed or Refractory Multiple Myeloma

NCT00306813 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
53
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University of Wuerzburg